Abstract | BACKGROUND: For patients undergoing colonoscopy with polypectomy, current guidelines recommend temporary cessation of blood-thinning medications. The data regarding periprocedural management of these medications are sparse. AIM: To perform a systematic review and meta-analysis to determine the risk of post-polypectomy bleeding (PPB) in patients taking anti-platelet, anti- coagulant and/or thienopyridine medications. METHODS: We searched Pubmed, Scopus, Web of Science, Biosis and Proceedings First from 1970 to 2015. PPB was defined as overt haemorrhage or drop in haemoglobin of at least 2 g/dL. RESULTS: Of 1490 articles identified, we included 3 papers and 1 abstract with patients on aspirin and/or NSAIDs, 1 paper on warfarin, 2 abstracts on clopidogrel, and 2 papers on clopidogrel plus aspirin and/or NSAIDs. While the rate of immediate PPB on aspirin and/or NSAIDs was not increased (OR = 1.1, 95% CI 0.7-1.9, P = 0.7), the risk of delayed PPB was increased (OR = 1.7, 95% CI 1.0-2.4, P = 0.0009, I(2) = 60%) but rendered non-significant with elimination of a small study. There was an elevated risk of delayed PPB on clopidogrel (OR = 9.7, 95% CI 3.1-30.8, P = 0.0, I(2) = 0). There was an increased risk of delayed PPB in patients on clopidogrel + aspirin and/or NSAIDs (OR = 3.4, 95% CI 1.3-8.8, P = 0.01, I(2) = 0). Based on a single study on warfarin, the PPB rate was elevated. There were no data regarding PPB and usage of the newer anti- coagulant agents. CONCLUSIONS:
|
Authors | D Shalman, L B Gerson |
Journal | Alimentary pharmacology & therapeutics
(Aliment Pharmacol Ther)
Vol. 42
Issue 8
Pg. 949-56
(Oct 2015)
ISSN: 1365-2036 [Electronic] England |
PMID | 26290157
(Publication Type: Journal Article, Meta-Analysis, Review, Systematic Review)
|
Copyright | © 2015 John Wiley & Sons Ltd. |
Chemical References |
- Anti-Inflammatory Agents, Non-Steroidal
- Anticoagulants
- Platelet Aggregation Inhibitors
- Pyridines
- thienopyridine
- Warfarin
- Aspirin
|
Topics |
- Anti-Inflammatory Agents, Non-Steroidal
(therapeutic use)
- Anticoagulants
(administration & dosage, adverse effects, therapeutic use)
- Aspirin
(therapeutic use)
- Blood Coagulation Disorders
(complications, drug therapy, epidemiology, surgery)
- Colonic Polyps
(complications, epidemiology, surgery)
- Colonoscopy
(adverse effects)
- Gastrointestinal Hemorrhage
(epidemiology, etiology)
- Humans
- Platelet Aggregation Inhibitors
(adverse effects, therapeutic use)
- Pyridines
(administration & dosage, adverse effects, therapeutic use)
- Risk Factors
- Warfarin
(therapeutic use)
|